Milestone Pharmaceuticals Inc. (NASDAQ:MIST – Get Rating) – Equities research analysts at Oppenheimer issued their FY2026 EPS estimates for shares of Milestone Pharmaceuticals in a research report issued to clients and investors on Monday, April 25th. Oppenheimer analyst L. Gershell expects that the company will post earnings of $1.03 per share for the year. Milestone Pharmaceuticals (NASDAQ:MIST – Get Rating) last announced its quarterly earnings results on Thursday, March 24th. The company reported ($0.
